Clinical Efficacy Observation of Interventional Therapy for Liver Metastasis of Digestive Tract Tumors
Objective This study aims to investigate the clinical efficacy of interventional therapy for liver metastasis of digestive tract tumors and the 1-year,3-year,and 5-year survival rates of patients.Methods This study selected 192 patients with liver metastasis of digestive tract tumors who were admitted to the First Affiliated Hospital of Henan University from February 2013 to February 2018.Through retrospective analysis of these patients'clinical records,the clinical efficacy and 1-year,3-year,and 5-year survival rates of patients with liver metastasis from different digestive system tumors who received interventional therapy were observed and analyzed.Results There were statistically significant differences(P＜0.05)in the complete remission rate,partial remission rate,stable disease rate,progressive disease rate,and treatment efficacy rate among patients with different primary tumor types.Among them,the treatment efficacy rate of gastric tumor patients was higher than that of colon tumor patients and pancreatic tumor patients,and the treatment efficacy rate of colon tumor patients was higher than that of pancreatic tumor patients,with statistically significant differences(P＜0.05).There were statistically significant differences(P＜0.05)in the 1-year,3-year,and 5-year survival rates among patients with different primary tumor types.Among them,the 1-year,3-year,and 5-year survival rates of gastric tumor patients were higher than those of colon tumor patients and pancreatic tumor patients,and the 1-year,3-year,and 5-year survival rates of colon tumor patients were higher than those of pancreatic tumor patients,with statistically significant differences(P＜0.05).Conclusion Interventional therapy can be used for patients with liver metastasis of digestive tract tumors who cannot be cured by surgery.There are certain differences in its efficacy for different tumor types,with pancreatic tumors showing poorer clinical performance compared to colon tumors and gastric tumors,and gastric tumor liver metastasis patients showing the best clinical performance.Clinicians should still be cautious when performing interventional therapy,choosing appropriate treatment plans based on the specific conditions of patients to avoid liver function damage caused by excessive use of chemotherapy drugs or over-embolization.
万方数据
维普
